Cresco Labs (CRLBF) Capital Expenditures (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Capital Expenditures came in at -$7.6 million in Q1 2026, down 31.28% YoY from -$11.1 million in Q1 2025, and down 112.47% on a QoQ basis from $61.3 million in Q4 2025.
Cresco Labs (CRLBF) Capital Expenditures (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Capital Expenditures data on file, last reported at -$7.6 million in Q1 2026.
- Quarterly Capital Expenditures fell 31.28% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (up 641.05% YoY) and the FY2025 annual result came in at $35.1 million, up 7071.02% from the prior year.
- Capital Expenditures retreated to -$7.6 million in Q1 2026, from $61.3 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $152.9 million in Q4 2022 to a low of -$39.8 million in Q2 2023.
- A 5-year average of $9.8 million and a median of -$7.2 million in 2025 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 265.12% in 2025, down 800.96% in 2025.
- Tracing CRLBF's Capital Expenditures over 5 years: stood at $152.9 million in 2022, then plunged by 30.71% to $106.0 million in 2023, then slumped by 84.16% to $16.8 million in 2024, then jumped by 265.12% to $61.3 million in 2025, then sank by 112.47% to -$7.6 million in 2026.
- The last three Capital Expenditures figures came in at -$7.6 million (Q1 2026), $61.3 million (Q4 2025), and -$7.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cresco Labs | 304.06 Mn | 239.95 Mn | 86.95 Mn | -9.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | 61.26 Mn |
| Dec 31, 2025 | 61.26 Mn |
| Sep 30, 2025 | -7.18 Mn |
| Sep 30, 2025 | -7.18 Mn |
| Jun 30, 2025 | -13.12 Mn |
| Jun 30, 2025 | -13.12 Mn |
| Mar 31, 2025 | -5.82 Mn |
| Mar 31, 2025 | -5.82 Mn |
| Dec 31, 2024 | 16.78 Mn |
| Dec 31, 2024 | 16.78 Mn |
| Sep 30, 2024 | -6.07 Mn |
| Sep 30, 2024 | -6.07 Mn |
| Jun 30, 2024 | -11.05 Mn |
| Jun 30, 2024 | -11.05 Mn |
| Mar 31, 2024 | 830,000.00 |
| Mar 31, 2024 | 830,000.00 |
| Dec 31, 2023 | 105.95 Mn |
| Dec 31, 2023 | 105.95 Mn |